AMRX Latest Press Releases

-- November 3, 2026 --

Amneal Reports Third Quarter 2026 Financial Results Globe Newswire 6:00 AM

-- October 8, 2026 --

Amneal to Report Third Quarter 2026 Results on November 3, 2026 Globe Newswire 8:00 AM

-- September 18, 2026 --

Amneal Announces FDA Approval and Launch of Lanreotide Injection Globe Newswire 4:01 PM

-- August 19, 2026 --

STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm Business Wire 8:00 AM

-- August 10, 2026 --

Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader Globe Newswire 8:00 AM

-- July 30, 2026 --

Amneal Reports Second Quarter 2026 Financial Results Globe Newswire 6:00 AM

-- July 23, 2026 --

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm Business Wire 1:27 PM

-- July 17, 2026 --

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations Globe Newswire 8:00 AM

-- July 9, 2026 --

Amneal to Report Second Quarter 2026 Results on July 30, 2026 Globe Newswire 4:05 PM

-- June 29, 2026 --

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations Globe Newswire 3:00 AM

-- June 10, 2026 --

Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals PRNewswire 10:09 AM

-- June 5, 2026 --

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT in Parkinson's Disease Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes